When it comes to treating disease, one promising avenue is addressing the presence of senescent cells. These cells—also known ...

This design converts a poorly soluble, weakly performing drug into a powerful, targeted cancer killer that leaves healthy cells unharmed. After developing the new therapy, the team tested it in a ...